Recalls for 05/16/2014

Ventlab Resuscitator Bags: Recall - Possible Health Risk
05/16/2014 Medical Recall

May result in delay of treatment, life threatening health consequences that include hypoxia and hypoventilation.

  • Company:
    Ventlab Resuscitator Bags
MV5 Days: Public Notification - Undeclared Drug Ingredient
05/16/2014 Medical Recall

May interact with nitrates found in some prescription drugs, and may lower blood pressure to dangerous levels.

  • Category
    Erectile Dysfunction
Asset Bold: Public Notification - Undeclared Drug Ingredient
05/16/2014 Medical Recall

Risk of increased blood pressure and/or pulse rate.

  • Category
    Heart
Hospira Announces Voluntary Nationwide Recall Of One Lot Of Labetalol Hydrochloride Injection, USP, 100 MG/20 ML (5MG/ML), 20 ML, Multidose Vial, Due To Visable Particulates
05/16/2014 Food Recall

Hospira, Inc. (NYSE: HSP), announced today it will initiate a voluntary nationwide recall to the user level for one lot of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL) 20 mL Multidose Vial, NDC 0409-2267-20, Lot 36-225-DD, Expiration 12/01/2015.

  • Company:
    Hospira
  • Problem
    Punctures In The Pouch Packaging
Ventlab, LLC. Issues a Nationwide Recall of Ventlab Resuscitator Bags Due to Possible Health Risk
05/16/2014 Food Recall

Ventlab LLC. of Grand Rapids, Michigan has initiated a voluntary medical device removal of a limited number of Ventlabâ„¢ Resuscitator Bags after becoming aware of complaints regarding a sticking duckbill valve that resulted in the resuscitation bags delivering no air through the patient valve, to the patient. The valves may stick due to incomplete curing during the manufacturing process.

  • Company:
    Ventlab LLC
  • Problem
    May Contain Undeclared Pine Nuts (Tree Nuts).
April 2014
05/16/2014 Medical Recall

Drug Safety Labeling Changes, April 2014

  • Category
    The Legend Of Zelda: A Link To The Past
Labetalol Hydrochloride Injection 100 MG/20 ML (5MG/ML), 20 ML, Multidose Vial by Hospira: Recall - Visible Particulates
05/16/2014 Medical Recall

Risk of injection site reactions and local irritation in the blood vessels, tissues and organs or delay in therapy.

  • Company:
    Hospira, Inc.